# A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.

> **NCT00775203** · PHASE3 · COMPLETED · sponsor: **Labopharm Inc.** · enrollment: 412 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Trazodone Hydrochloride (HCl) Extended-Release Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00775203
- **Lead sponsor:** Labopharm Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 412 (ACTUAL)
- **Last updated:** 2012-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00775203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00775203, "A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00775203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*